Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024:49:1-18.
doi: 10.1007/978-3-031-42398-7_1.

Molecular Biomarkers Affecting Moyamoya Disease

Yong-Kwang Tu  1   2 , Yao-Ching Fang  3
Affiliations

Molecular Biomarkers Affecting Moyamoya Disease

Yong-Kwang Tu et al. Adv Tech Stand Neurosurg. 2024.

Abstract

Although the pathogenetic pathway of moyamoya disease (MMD) remains unknown, studies have indicated that variations in the RING finger protein RNF 213 is the strongest susceptible gene of MMD. In addition to the polymorphism of this gene, many circulating angiogenetic factors such as growth factors, vascular progenitor cells, inflammatory and immune mediators, angiogenesis related cytokines, as well as circulating proteins promoting intimal hyperplasia, excessive collateral formation, smooth muscle migration and atypical migration may also play critical roles in producing this disease. Identification of these circulating molecules biomarkers may be used for the early detection of this disease. In this chapter, how the hypothesized pathophysiology of these factors affect MMD and the interactive modulation between them are summarized.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288–99. - PubMed - DOI
    1. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226–37. - PubMed - DOI
    1. Shang S, et al. Progress in moyamoya disease. Neurosurg Rev. 2020;43(2):371–82. - PubMed - DOI
    1. Dorschel KB, Wanebo JE. Genetic and proteomic contributions to the pathophysiology of moyamoya angiopathy and related vascular diseases. Appl Clin Genet. 2021;14:145–71. - PubMed - PMC - DOI
    1. Goto Y, Yonekawa Y. Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo). 1992;32(12):883–6. - PubMed - DOI

MeSH terms